Introduction {#s1}
============

The safety and efficacy of electroconvulsive therapy (ECT) in patients with a brain tumor were debated in the past without a clear conclusion. In the last large review published by Maltbie et al. ([@B1]) in 1980, it was deemed that the presence of an intracranial mass should be considered an absolute contraindication to ECT. In our updated review, we investigated a total of 33 published and indexed case reports, case report series, and reviews of 75 individual patients who underwent ECT in the presence of a brain tumor over the last 80 years.

Study Aim {#s2}
=========

The main aim of our review was to find out whether the original conclusion of Maltbie et al. ([@B1]) (the presence of a brain tumor should be considered an absolute contraindication to ECT) can be challenged by collecting and analyzing all case reports, case report series, or mini reviews that emerged on this topic since the publication of this review 40 years ago. Our secondary goal was to provide a comprehensive overview about the occurrence and severity of adverse effects (AEs) after ECT in patients with a brain tumor and find possible methods to increase the safety of this important treatment modality in current scientific literature.

Methods {#s3}
=======

We followed the PRISMA statement ([@B2]) as a guide for conducting our systematic review. We have searched the electronic databases of Cochrane, PubMed, Journal of ECT, Biological Psychiatry, and Brain Stimulation using combinations of terms "electroconvulsive therapy," "brain tumor," and "electroconvulsive therapy," "intracranial mass," and "ECT," "brain tumor." The search was last updated in May 2020. The electronic search returned 651 abstracts and titles. We screened these abstracts and excluded studies that were duplicates or not directly relevant to the topic of this review. Our inclusion criteria were all original studies---case reports, letters to the Editor, case report series, mini reviews, reviews, or book chapters that reported on patients who underwent ECT with a previously known presence of a brain tumor OR patients in which the brain tumor was discovered during/shortly after a course of ECT. We excluded papers that revolved around the application of ECT in patients after tumor resection, aneurysms, or other vascular malformations; patients with a severe disease or malformation of the central nervous system (hydrocephalus, encephalitis, etc.) ([@B3]); and patients with tumors that were outside the intracranial space. Only papers in English were considered for this review. Further details are provided in [Figure 1](#F1){ref-type="fig"}.
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The case reports up to 1980 were varied in the details provided---most of them lack the exact description of the type of ECT, stimulation parameters, device, and electrode placement ([Table 1](#T1){ref-type="table"}) and were already discussed in the Maltbie et al. ([@B1]) review. Nonetheless, we have summarized the available data from these individual case reports in [Table 1](#T1){ref-type="table"}. Because of the large variability in the quality of these articles up to 1980, we have focused our attention to summarize newer case reports, case report series, or mini reviews published between 1984 and 2020 ([Table 2](#T2){ref-type="table"}).

###### 

ECT in patients with a brain tumor 1946--1980.

  **Study**                         **Sex**   **Age**   **Neurological symptoms prior to ECT**                             **Type of tumor**         **Localization**                              **Was tumor presence known before ECT?**   **Type of ECT**                           **Number of ECT applications**   **Adverse Effects after ECT**
  --------------------------------- --------- --------- ------------------------------------------------------------------ ------------------------- --------------------------------------------- ------------------------------------------ ----------------------------------------- -------------------------------- ------------------------------------------------------------------------------------
  Rond ([@B4])                      M         42        No                                                                 Glioma                    Pons                                          No                                         Unkown                                    3                                Long-term confusion and ataxia
  Dressler et al. ([@B5])           F         66        No                                                                 Metastasic carcinoma      Left parietal and left occipital lobe         Yes                                        Unkown                                    7                                No
  Shapiro and Goldberg ([@B6])      M         60        No                                                                 Meningioma                Frontal lobe                                  No                                         Unidirectional current (Reiter machine)   3                                Long-term confusion
  Shapiro and Goldberg ([@B6])      M         39        Neck and facial pain                                               Meningioma                Right sphenoidal ridge                        No                                         Unidirectional current (Reiter machine)   6                                Long-term confusion
  Shapiro and Goldberg ([@B6])      M         70        Dyscalculia, hand extiction                                        Glioblastoma multiforme   Right fronto-temporal region                  No                                         Unidirectional current (Reiter machine)   7                                Long-term confusion, aphasia
  Shapiro and Goldberg ([@B6])      M         69        Memory defects, truncal ataxia                                     Glioblastoma              Corpus callosum                               No                                         Unidirectional current (Reiter machine)   5                                Long-term confusion
  Shapiro and Goldberg ([@B6])      M         47        Paresis of the right lower extremity, severe recurrent headaches   Glioblastoma              Left frontal lobe                             No                                         unidirectional current (Reiter machine)   4                                Aphasia
  Shapiro and Goldberg ([@B6])      M         56        No                                                                 Glioblastoma              Left temporo-parietal region                  No                                         Unidirectional current (Reiter machine)   2                                No
  Gassel ([@B7])                    F         42        Headaches with vomiting                                            Meningioma                Right frontal lobe                            No                                         Unknown                                   1                                Long-term confusion, weakness in all limbs
  Gassel ([@B7])                    F         40        Weakness in right lower extremity                                  Meningioma                Left parietal lobe                            No                                         Unknown                                   4                                Memory deficit complaints, weakness in all limbs
  Gassel ([@B7])                    F         55        Headaches with vomiting, indeterminate right plantar response      Meningioma                Right parieto-occipital lobe                  No                                         Unknown                                   4                                Aphasia, right miosis, bilateral acute papiledema, spasticity of lower extremities
  Gralnick ([@B8])                  M         60        No                                                                 Meningeal fibroblastoma   Both frontal lobes                            No                                         Unidirectional current                    2                                Coma
  Cole ([@B9])                      M         33        No                                                                 Oligodendroglioma         Left frontal lobe + both lateral ventricles   No                                         Unknown                                   5                                Long-term confusion, coma
  Delay et al. ([@B10])             F         42        No                                                                 Glioma                    Left-parieto-temporal region                  No                                         Unknown                                   6                                Secondary seizure after ECT with right-sided lateralisation
  Malamud ([@B11])                  M         47        Epileptiformn attacks                                              Astrocytoma               Left temporal lobe                            No                                         Unknown                                   Unknown                          No
  Malamud ([@B11])                  F         27        No                                                                 Astrocytoma               Right fronto-parietal region                  No                                         Unknown                                   Unknown                          Left-side spasticity
  Malamud ([@B11])                  M         26        No                                                                 Glioma                    Hippocampus                                   No                                         Unknown                                   Unknown                          Epileptic seizures after combined ECT/inzuline treatment
  Malamud ([@B11])                  F         47        Epilepsy                                                           Astrocytoma               Left temporal lobe                            No                                         Unknown                                   Unknown                          Syncopes after ECT and one record of transient aphasia
  Malamud ([@B11])                  M         33        Epilepsy                                                           Astrocytoma               Left frontal lobe                             No                                         Unknown                                   Unknown                          Coma
  Malamud ([@B11])                  F         48        No                                                                 Craniopharyngioma         Third ventricle                               No                                         Unknown                                   Unknown                          Dysarthria and subbsequent coma
  Malamud ([@B11])                  M         28        No                                                                 Colloid cyst              Third ventricle                               No                                         Unknown                                   Unknown                          Coma
  Paulson ([@B12])                  F         49        Headache, dyscomfort in right shoulder                             Metastatic carcinoma      Right parietal lobe                           No                                         Unknown                                   1                                Coma
  Paulson ([@B12])                  M         20        Head and neck pain                                                 Sarcoma                   Cerebellum                                    No                                         Unknown                                   6                                Coma, bilateral papiloeadema with hemorrhages
  Paulson ([@B12])                  F         57        Headache, difficulty writing                                       Metastatic carcinoma      Left frontal lobe                             No                                         Unknown                                   1                                Aphasia, weakness in right upper and lower limb
  Kalinowski and Kippins ([@B13])   Unknown   Unknown   Unknown                                                            Unknown                   Unknown                                       No                                         Unknown                                   Unknown                          Unknown
  Maltbie et al. ([@B1])            F         48        Ataxia                                                             Meningioma                Olfactory groove                              No                                         Unknown                                   1                                Coma
  Maltbie et al. ([@B1])            M         46        No                                                                 Glioblastoma multiforme   Left parietal lobe                            No                                         Unknown                                   1                                Long-term confusion, aphasia, left-sided hyperreflexion
  Maltbie et al. ([@B1])            F         48        Epilepsy                                                           Glial tumor               Both frontal lobes                            No                                         Unknown                                   6                                Ataxia, right hemiparesis, withdrawal
  Maltbie et al. ([@B1])            M         63        No                                                                 Glioblastoma              Occipital region                              No                                         Unknown                                   12                               Persistent headache for 5 months
  Maltbie et al. ([@B1])            M         38        No                                                                 Oligodendroglioma         Right fronto-temporal region                  No                                         Unknown                                   15                               Sleepiness, left hemiplegia, deviation of the eyes to the left
  Maltbie et al. ([@B1])            F         28        No                                                                 Dermoid cyst              Cerebello-pontine region                      No                                         Unknown                                   1                                No
  Maltbie et al. ([@B1])            F         80        No                                                                 Glioblastoma              Left frontal lobe                             No                                         Unknown                                   1                                Right hemiplegia
  Waggoner and Bagchi ([@B15])      F         50        No                                                                 Menignioma                Left cerebellar hemishpere                    No                                         Unknown                                   12                               No
  Waggoner and Bagchi ([@B15])      F         54        No                                                                 Glioblastoma multiforme   Right temporo-parietal region                 Yes (suspected)                            Unknown                                   3                                Left facial paresis, confusion
  Waggoner and Bagchi ([@B15])      F         37        Chronic headache and dizziness                                     Oligodendroglioma         Left frontal lobe                             No                                         Unknown                                   Unknown                          No

###### 

ECT in patients with a brain tumor 1984--2020.

  **Study**                           **Sex**   **Age**   **Indication (symptoms)**          **Neurological symptoms prior to ECT**               **Type of tumor**           **Size (cm)**       **Localization**                 **Was tumor known before ECT**   **Type of ECT**   **no. of ECT**   **Adverse Effects after ECT?**                               **Was ECT beneficial?**   **Was ECT discontinued?**   **Notes**
  ----------------------------------- --------- --------- ---------------------------------- ---------------------------------------------------- --------------------------- ------------------- -------------------------------- -------------------------------- ----------------- ---------------- ------------------------------------------------------------ ------------------------- --------------------------- -------------------------------------------------------------------
  Hsiao and Evans ([@B14])            F         50        Severe depression with psychosis   No                                                   Meningioma                  Unknown             Left parietal lobe               Yes                              Brief             18               No                                                           Yes                       No                          
  Fried and Mann ([@B16])             M         85        Severe depression with psychosis   No                                                   Meningioma                  2.0                 Left frontal lobe                Yes                              Brief             11               No                                                           Yes                       No                          Patient received phenytoin prior ECT to prevent prolonged seizure
  Greenberg et al. ([@B17])           F         75        Severe depression with psychosis   No                                                   Meningioma                  3.0 × 3.0           Fronto-temporo-parietal region   Yes                              Brief             8                No                                                           Yes                       No                          
  Goldstein and Richardson ([@B18])   F         74        Severe depression                  No                                                   Meningioma                  1.0 × 1.5           right frontal lobe               Yes                              Brief             6                No                                                           Yes                       No                          
  Malek-Ahmadi and Sedler ([@B19])    F         73        Severe depression                  No                                                   Meningioma                  0.5                 Fronto-parietal region           Yes                              Brief             7                No                                                           Yes                       No                          
  Zwil et al. ([@B20])                F         73        Severe depression with psychosis   No                                                   Meningioma                  2.0                 Cerebello-pontine region         Yes                              Brief             10               Post-ictal confusion                                         Yes                       No                          Patient received dexamethasone prior ECT
  Zwil et al. ([@B20])                F         71        Severe depression with psychosis   No                                                   Meningioma                  1.0 × 1.0           Left frontal lobe                Yes                              Brief             12               No                                                           Yes                       No                          
  Zwil et al. ([@B20])                F         78        Psychosis                          No                                                   Meningioma                  2.0                 Left parietal lobe               Yes                              Brief             10               Post-ictal confusion                                         Yes                       No                          
  Mattingly et al. ([@B21])           F         75        Severe depression                  No                                                   metastatic carcinoma        1.2 × 1.2           cerebellar region                Yes                              Brief             11               No                                                           Yes                       No                          Patient received dexamethasone prior ECT
  Holroyd ([@B22])                    F         83        catatonia                          No                                                   Meningioma                  1.5 × 1.5           Left frontal lobe                Yes                              Brief             18               No                                                           Yes                       No                          
  Holroyd ([@B22])                    F         83        Severe depression                  No                                                   Meningioma                  2.0 × 2.0           Cerebellar region                Yes                              Brief             20               No                                                           Yes                       No                          
  Holroyd ([@B22])                    M         76        Severe depression with psychosis   No                                                   Unknown                     Unknown             Pitiutary gland                  No                               Brief             7                No                                                           Yes                       Yes                         Discontinued after dg. of tumor due to previous reports
  Holroyd ([@B22])                    F         65        Severe depression                  Left hyperreflexia and + Babinski, oral dyskinesia   Meningioma                  1.5 × 1.5           Left frontal lobe                Yes                              Brief             5                No                                                           Yes                       No                          
  Holroyd ([@B22])                    M         60        Psychosis                          Left hypoacusia                                      Acoustic neuroma            4.0                 Left posterior fossa             No                               Brief             11               No                                                           Yes                       No                          
  Kellner and Rames ([@B23])          F         75        Severe depression with psychosis   No                                                   Meningioma                  1.7 × 1.0           Left fronto-temporal region      Yes                              Brief             9                No                                                           Yes                       No                          Patient received dexamethasone prior ECT
  Rasmussen et al. (35)               M         71        Psychosis                          No                                                   Unknown                     1.5 × 1.0           Left parietal lobe               No                               Brief             Unknown          No                                                           Yes                       No                          
  Rasmussen et al. ([@B24])           M         59        Severe depression                  No                                                   Unknown                     0.2                 Thalamus                         Yes                              Brief             9                No                                                           Yes                       No                          
  Rasmussen et al. ([@B24])           M         57        Severe depression                  No                                                   Unknown                     1.2 parasagitally   Right basal forebrain            No                               Brief             6                No                                                           Yes                       No                          
  Rasmussen et al. ([@B24])           F         73        Severe depression                  6th nerve palsy                                      Meningioma                  1.0 × 1.7           Ponto-cerebellar region          No                               Brief             Unknown          No                                                           Yes                       No                          
  Rasmussen KG et al. 2007            F         80        Severe depression                  hypersomnia                                          cystic mass                 3.3 × 2.9 × 3.4     Frontal lobe                     No                               Brief             Unknown          No                                                           No                        Yes                         
  Rasmussen et al. ([@B24])           M         44        Severe depression                  No                                                   Unknown                     Unknown             Ponto-medullary region           Yes                              Brief             8                No                                                           Yes                       No                          
  Rasmussen et al. ([@B24])           F         33        Severe depression                  No                                                   Microadenoma                0.35                Sellar region                    Yes                              Brief             10               No                                                           Yes                       No                          
  Buday et al. ([@B25])               F         42        Severe depression with psychosis   No                                                   Unknown-likely Meningioma   1.6 × 1.0           Left parietal lobe               No                               Ultrabrief        7                Secondary seizure after ECT                                  Yes                       Yes                         
  Gani and Parvez ([@B26])            F         70        psychosis                          No                                                   Meningioma                  Unknown             Left frontal lobe                Yes                              Ultrabrief        12               No                                                           Yes                       No                          
  Patkar et al. ([@B27])              M         61        Severe depression                  Elevated IP                                          Astrocytoma                 Unknown             Left temporal lobe               Yes                              Brief             8                No                                                           Yes                       No                          Patient received dexamethasone prior ECT
  Fischer ([@B28])                    F         80        Severe depression                  No                                                   Gliolastoma multiforme      Unknown             Corpus callosum                  No                               Ultrabrief        7                Post-ictal confusion, ataxia                                 No                        Yes                         
  Perry et al. ([@B29])               F         53        Severe depression                  No                                                   Arachnoid cyst              4.0 × 4.4 × 1.6     Left-frontoparietal convex.      Yes                              Unknown           11               No                                                           Yes                       No                          
  Perry et al. ([@B29])               M         58        psychosis with agitation           No                                                   Arachnoid cyst              1.3 × 4.3 × 1.4     Left posterior fossa             Yes                              Unknown           21               No                                                           Yes                       No                          
  Perry et al. ([@B29])               M         43        Severe depression                  No                                                   Arachnoid cyst              2.0 × 2.0 × 2.5     Midline posterior fossa          Yes                              Unknown           14               No                                                           Yes                       No                          
  Perry et al. ([@B29])               M         19        Mania with psychosis               No                                                   Arachnoid cyst              3.0 × 5.0 × 4.0     middle cranial fossa             Yes                              Unknown           1                No                                                           No                        Yes                         Patient refused further ECT (reason not stated)
  Perry et al. ([@B29])               M         42        Catatonia                          No                                                   Arachnoid cyst              2.6 × 1.2 × 2.9     Left posterior fossa             No                               Unknown           5                No                                                           Yes                       No                          
  Perry et al. ([@B29])               M         44        Severe depression with psychosis   No                                                   Arachnoid cyst              1.3 × 3.5 × 2.3     Middle cranial fossa             Yes                              Unknown           5                No                                                           Yes                       No                          
  Huang et al. ([@B30])               F         58        Severe depression                  No                                                   Acoustic neuroma            3.3 at CP angle     Left cerebello-pontine angle     No                               Brief             6                Post-ictal confusion, delirium, nausea, hearing impairment   No                        Yes                         
  Desseilles et al. ([@B31])          M         58        Severe depression                  No                                                   Arachnoid cyst              7.6 × 4.1 × 8.1     Right anterior temporal reg.     Yes                              Brief             7                No                                                           Yes                       No                          
  Hanretta et al. ([@B32])            F         29        Severe depression with psychosis   No                                                   Arachnoid cyst              2.5 × 2.5           Right temporal lobe              Yes                              Brief             6                No                                                           Yes                       No                          
  Kastenholz et al. ([@B33])          F         21        Catatonia                          No                                                   Arachnoid cyst              4.6 × 8.8 × 4.0     Posterior fossa                  Yes                              Brief             6                No                                                           Yes                       No                          
  Escalona et al. ([@B34])            M         53        Severe depression                  No                                                   Arachnoid cyst              Unknown             Left sylvian fissure             Yes                              Unknown           Unknown          No                                                           Yes                       No                          
  Restifo and Paterson ([@B35])       M         22        Psychosis                          No                                                   Colloid cyst                Unknown             Third ventricle                  Yes                              Unknown           9                No                                                           Yes                       No                          
  Grover et al. ([@B36])              F         57        Severe depression with psychosis   No                                                   Arachnoid cyst              3.4 × 1.6           Left temporal region             No                               Unknown           12               Post-ictal confusion                                         Yes                       No                          
  Mckinney et al. ([@B37])            F         66        mania                              No                                                   Meningioma                  1.0                 cerebellum                       Yes                              Brief             8                No                                                           Yes                       No                          

Outcome data were determined by scoring several questions:

-   Were there any neurological symptoms present before ECT?

-   Was the presence of the tumor known before ECT?

-   What was the type of ECT used---pulse width, electrode placement, dosage, titration strategy?

-   Were there any AEs present after ECT, especially neurological and lateralizing symptoms?

-   Was ECT discontinued due to the presence of any AEs?

-   What was the indication for ECT?

-   Was the application of ECT beneficial for the patients according to the authors of the respective case report?

-   How many sessions of ECT were applied?

-   Were any precautionary measures undertaken if the presence of the brain tumor was known before ECT application?

Despite the large variation in quality and quantity of the information provided, we were also able to sort patients by their biological sex, age, type, localization, and size of the tumor.

Study Limitations {#s4}
=================

The main bias of our review is the fact that the topic of ECT and brain tumor is likely underreported in general. The same weakness was pointed out by Maltbie et al. ([@B1]) in their original study from 1980. It is very likely that a substantial amount of patients with an undiagnosed brain tumor undergo this treatment without any observable side effects and are therefore not reported in scientific literature. On the other hand, it is possible that AEs after ECT treatment in this subgroup of patients are also underreported, as the newer case reports after 1980 consist largely of patients with clinically insignificant tumors. More advanced investigations, such as the analysis of registry-based data \[health maintenance organization (HMO)/insurance claims, government regulation data\] could provide a more clear and complex view of this topic.

Another weakness is the varied quality of the presented case reports. In particular, the authors generally did not specify as to how exactly the AEs were monitored after ECT (nor to what extent the patients were neurologically examined prior to ECT). It is therefore possible that these patients did manifest discreet symptoms that were not noticed and only the more obvious AEs were reported.

Results {#s5}
=======

Starting from the first case report by Hsiao and Evans ([@B14]) in 1984 up to our own in 2019, we reviewed a total of 40 patients, which represents a comparable size-sample to the one analyzed by Maltbie et al. ([@B1]) between the years 1945 and 1980 (total of 35). In contrast with the previous review, the presence of a brain tumor was known before ECT in 29 patients (72.5%). Brief pulse width ECT was administered to 28 patients, ultrabrief pulse width to three, and in nine patients, we were unable to trace the pulse width.

The most common indication for ECT in this group of patients was severe depression (18 patients−45%) and psychosis, usually associated with a severe mood disorder (18 patients−45%). Three patients were indicated for ECT due to symptoms of catatonia and one patient for mania.

The most common type of tumor was a meningioma, which was present in 16 patients (40%), with arachnoid cysts coming in second place with 11 patients (27.5%).

Six patients (15% of the sample) manifested AEs after ECT. Out of this group, four patients developed postictal confusion; one patient manifested a set of several unusual, but reversible, symptoms (secondary myoclonic seizure with lateralization unresponsive to intravenous diazepam application, ping-pong gaze, and Todd\'s paralysis); and one patient was observed to develop a 3-day-long delirium with hearing impairment. All reported AEs were reversible.

ECT was discontinued in six patients (15%)---the first described by Holroyd ([@B22]) in 1993, where the treatment was stopped immediately after a random CT scan revealed a tumor in the pituitary area. Ironically, the patient did not show any AEs during ECT administration, and at the time, it was stopped only due to the previous series of negative case reports on the topic. The second cessation of ECT was in the case of an 80-year-old woman due to terminal-stage cancer ([@B24]). In another two cases, the ECT was canceled due to lack of effect and refusal to continue with the procedure from the side of the patient ([@B28], [@B29]). Huang et al. ([@B30]) described a patient who developed severe AEs after ECT including nausea, hearing loss, and a 3-day delirium---the patient was later diagnosed with acoustic neuroma, and ECT was discontinued. And finally, in our department, we halted ECT in a female patient who manifested a secondary seizure and was subsequently found to have an intracranial tumor in the left parietal lobe ([@B25]).

Five patients (12.5%) had neurological symptomatology prior to the administration (including one report of a patient with an elevated intracranial pressure), but none of them manifested any AEs following ECT administration. Five patients were premedicated with dexamethasone to prevent acute edema or phenytoin to prevent secondary seizures.

According to the authors of the respective case reports, ECT was beneficial for 36 patients (90%). ECT was ineffective in three cases and discontinued in one patient after he refused to undergo further treatment (the reason behind this decision was not stated).

Only one patient ([@B27]) was reported to have had elevated intracranial pressure prior to the procedure, and he underwent ECT without any AEs.

In this group of patients, we were able to determine the exact number of ECT sessions in 36 patients. The average number of sessions per patient was 9.47.

No patient was reported to have died as a result of ECT application in this sample. The average age of patients in this group was 59.72 years.

Discussion {#s6}
==========

There seems to be a clear difference between the two similarly sized groups from 1945 to 1980 and 1984 to 2019. However, our results must also be seen as biased---the topic of ECT and brain tumor is likely in general underreported; in the majority (72.5%) of these new case reports, the presence of the brain tumor was known prior to ECT application which had allowed undertaking specialized precautions ([@B23]) (dexamethasone or phenytoin administration) in a substantial number of patients (12.5%), and last but not least, 40% of these reports constitute patients with benign meningiomas or clinically insignificant tumors, which is in contrast to the group of patients reported on by Maltbie et al. ([@B1]), where this group represents only seven patients (20%). It should be noted that the latter review consisted of a substantial amount of patients with more aggressive and clinically more significant tumors, such as gliomas ([Table 1](#T1){ref-type="table"}). We also point out a difference between patients with neurological symptoms manifesting prior to ECT administration-−12.5% of patients in the new group and 45.7% in the Maltbie et al. ([@B1]) sample.

Despite this bias, the case reports between 1984 and 2019 demonstrate that ECT can be applied safely in certain patients with an intracranial mass. The average number of ECT sessions was 9.47 in this group compared to 4.57 in the older group. Six patients manifested AEs after the treatment---out of these, only two patients discontinued treatment due to their presence. All AEs in the 1984--2019 sample were reversible, and the majority constituted of patients who were confused after the procedure---an AE not that rare even in patients undergoing ECT without a brain tumor.

We know that seizure activity increases blood pressure and cerebral blood flow, which can lead to an increased edema around the tumor and subsequently to an increase in intracranial pressure and eventually manifestation of neurological signs. This mechanism was first proposed by Carter ([@B38]) in 1977 and considered to be the likely cause of the more prominent AEs in this review reported by Huang et al. ([@B30]) and Buday et al. ([@B25]).

Dexamethasone was used in a substantial amount of patients (12.5%) to reduce the risk of this pathophysiological mechanism in the newer set of case reports. Phenytoin was administered to one patient to prevent a prolonged seizure. None of these individuals manifested AEs; it is therefore possible that the administration of these substrates prior to ECT may reduce the risk of an acute edema and prolonged seizure, respectively.

In their review, Maltbie et al. ([@B1]) suggested that more invasive and aggressive tumors might result in a higher incidence of AEs during ECT. The majority of patients in the newer case reports had benign, small, and clinically insignificant tumors, which seem to support the conclusion that this type of lesion poses a minimal risk increase in regard to ECT application. However, as several new case reports mention in this review, some patients with a brain tumor (especially a previously undiagnosed lesion) can manifest reversible, but unusual and concerning, AEs. Currently, neuroimaging is not mandatory before initiating ECT---it was reported several times that the yield of organic pathology if performed in all patients before undergoing ECT is very low ([@B34], [@B39], [@B40]). We suggest that any new neurological symptoms manifesting during and after ECT (such as a significant lateralization of the seizure, Todd\'s paralysis, aphasia, eye-movement disorders, secondary seizures, etc.) should prompt a complex neurological investigation and neuroimaging to exclude the presence of an intracranial mass (which might, depending on its localization, play a role in the psychopathology due to which ECT was indicated in the first place), another organic disease of the central nervous system, or even an acute problem, such as intracranial bleeding.

We must also consider that technological advancement and modern titration strategies that seek to individualize the dosage in each patient might also be one of the reasons why there are less and far more benign and reversible reported AEs ([@B41]). Unfortunately, in most cases between 1945 and 1980, it was not possible to track the type of devices, titration strategy, and dosage levels used during ECT. Based on the review of case reports emerging since 1984, it seems that the application of ECT is safer than it was originally presumed by Maltbie et al. ([@B1]) in 1980, and this method can be applied safely on a case-by-case basis.

Conclusion {#s7}
==========

We have reviewed a total of 33 articles of 75 individual patients who underwent ECT in the presence of a brain tumor over the last 80 years. Mounting case reports from 1984 show that this method can be safely administered in patients with benign, small, and otherwise clinically insignificant tumors. The application of ECT in this type of patients should be considered in a case-by-case basis after interdisciplinary consultation with a neurologist and neurosurgeon with a risk/benefit assessment. ECT practitioners should be vigilant of any AEs (especially neurological) manifesting during and after the procedure. The occurrence of such abnormal symptoms should prompt an immediate neurological investigation and proper imaging studies to exclude any underlying organic pathology. Certain precautionary measures, such as dexamethasone or phenytoin application before ECT, could lead to a further minimalization of AEs.
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